Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

The Alex Manfull Memorial Fund: Supporting Research, Education and Treatment of PANDAS in Adolescents and Young Adults

PANDAS/PANS Symposium to be held in Portsmouth, NH: Expert Physicians and Researchers Present Advances in Understanding Post-Infectious Autoimmune Encephalitis


News provided by

The Alex Manfull Memorial Fund

Sep 26, 2019, 11:00 ET

Share this article

Share toX

Share this article

Share toX


PORTSMOUTH, N.H., Sept. 26, 2019 /PRNewswire-PRWeb/ -- The grieving parents of a brilliant daughter, who lost her life to a debilitating autoimmune encephalitis disorder called PANDAS, are launching their first public event aimed at combating such disorders. The day-long symposium will take place on October 26 in Portsmouth, NH.

Susan and William Manfull established The Alex Manfull Memorial Fund Supporting Research, Education, and Treatment of PANDAS in Adolescents and Young Adults, with the goal that no life ever again be cut short by PANDAS.

The Manfulls are hopeful that physicians, psychologists and other mental health workers, school nurses, and other professionals working with young patients will want to learn more about PANDAS and PANS so that they can recognize and diagnose these disorders and treat them promptly.

Post this

Entitled "PANDAS/PANS: Advances in Diagnosis and Treatment for Post-Infectious Autoimmune Basal Ganglia Encephalitis," this day-long symposium has the explicit goal of increasing awareness and education about these devastating and sometimes deadly disorders. The event coincides with the recent passage of NH Senate Bill 224, that requires insurance companies to provide coverage for treatment of "pediatric autoimmune neuropsychiatric disorders." It will include presentations by some of the nation's top physicians and researchers in this relatively new field — all focused on spreading the word about recognizing and treating these very serious disorders.

Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (PANDAS) and Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) refer to disorders involving sudden-onset neuropsychiatric symptoms such as obsessions and compulsions, self-restricted food intake, separation anxiety, motor and/or vocal tics, emotional lability, personality changes, aggression and rage.

With PANDAS, symptoms surface after exposure to Group A Streptococcus; in the case of PANS, acute symptoms can present with or without a specifically identified trigger (e.g., following an infection such as mycoplasma pneumonia, flu, Lyme disease or a metabolic disorder). These disorders typically present before puberty, but also may surface for the first time in adolescence and young adulthood.

Among the speakers will be the leading practitioners and researchers in this emerging field:

  • Tyler Cutforth, PhD (Molecular and Cell Biologist/ Researcher at Agalliu Lab, Department of Neurology, Columbia University)
  • Nancy Dougherty (Education & Communications Consultant for the Johns Hopkins Lyme Disease Research Center).
  • Earl H. Harley, Jr., MD (Pediatric Otolaryngologist and Professor, Department of Otolaryngology, Georgetown University)
  • Pawel Kiela, DVM, PhD (Endowed Professor in Autoimmune Disease Research, Steele Children's Research Center and the Departments of Pediatrics and Immunobiology, University of Arizona)
  • Beth Latimer, MD (Pediatric Neurologist specializing in the area of PANDAS/PANS, founder of the Latimer Neurology Center in D.C.)
  • John McDermott, MD (retired Cardiac Surgeon and parent of a young adult with PANDAS/PANS)
  • Mark S. Pasternack, MD (Chief of Pediatric Infectious Disease, Massachusetts General Hospital)
  • Kyle Williams, MD, PhD (Director of the Pediatric Neuropsychiatry and Immunology Program in the OCD and Related Disorders Program at Massachusetts General Hospital/Instructor in Psychiatry at Harvard Medical School)
  • The Keynote Speaker will be James Giordano, PhD (Chief, Neuroethics Studies Program and Professor, Department of Neurology, Georgetown University Medical Center).

New Hampshire was the fifth state to pass legislation requiring insurance companies to cover treatment and is the only state in the northeast to mandate such coverage. The Manfulls are hopeful that physicians, psychologists and other mental health workers, school nurses, and other professionals working with young patients will want to learn more about PANDAS and PANS so that they can recognize and diagnose these disorders and treat them promptly. It is critical that these disorders be recognized as early as possible for treatment to be most effective. Thus, the symposium's target audience is health practitioners although there will be room for other interested individuals.

Born and raised in Portsmouth, NH., Alex Manfull was a graduate of Phillips Exeter Academy and Princeton University. A rising star on Wall Street, she had just started an exciting job in finance in Washington, D.C. She had her whole life before her when she succumbed to PANDAS at 26 years old.

From earliest childhood, Alex also distinguished herself as an intrinsically motivated and talented artist and writer as well as a gifted athlete. The symposium will coincide with a retrospective exhibition of her artwork at the Seacoast African American Cultural Center, located in the Discover Portsmouth Center where the symposium will be held, in downtown Portsmouth, NH.

This symposium was made possible through a generous gift from the Minerva Foundation. Special thanks to PANDAS Network for their support of the symposium and for the work they do every day in helping PANDAS/PANS patients and families.

Entrance to the art exhibition is free although donations are most welcome. The fee to attend the day-long symposium is $85. Please visit https://alex-manfull-memorial-fund.eventcreate.com/ to register. All fees will go to The Alex Manfull Memorial Fund Supporting Research, Education, and Treatment of PANDAS in Adolescents and Young Adults.

About The Alex Manfull Memorial Fund:
This fund was established in the hope that other young adults, as well as children and adolescents, shall have greater treatment options and that never again will another life be cut short due to PANDAS. http://www.TheAlexManfullMemorialFund.com

About PANDAS Network:
PANDAS Network is 501c3 organization dedicated to improving the diagnosis and treatment of children with PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections) and PANS (Pediatric Acute-onset Neuropsychiatric Syndrome). Armed with an impressive network of doctors, researchers and scientists, PANDAS Network strives to collaborate with subject matter experts, build public awareness, provide family support, and gather data and resources to better inform parents and the medical community about PANDAS and PANS. http://www.PandasNetwork.org

To register, or for more information about the symposium, Alex Manfull, or the art exhibition,
please visit https://alex-manfull-memorial-fund.eventcreate.com or contact Susan Manfull at
(603) 828-1766 or [email protected]

SOURCE The Alex Manfull Memorial Fund

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.